Search Close Search
Search Close Search
Page Menu

"Speaking of Vitiligo..."

I am a physician-scientist who focuses my clinical and research efforts on vitiligoI am a physician-scientist who focuses my clinical and research efforts on vitiligo, and therefore I think about this disease a lot – all the time, in fact. Therefore I thought it would be helpful to share my thoughts with others who are interested in vitiligo as well, particularly the patients who suffer from it and their loved ones. I want to make clear that while I am affiliated with many vitiligo organizations, my comments in this blog are my own, and do not reflect the opinions of those organizations. In addition, my research is largely focused on finding new treatments, and ultimately a cure, for vitiligo. This work is supported by a number of sources, including pharmaceutical companies, which by definition creates potential conflicts of interest. In full disclosure, here is a list of our vitiligo research supporters. Please know that, to the best of my ability, all of my comments are unbiased reflections of my understanding of vitiligo as both a physician and scientist. I do not permit advertisements on my website, and do not endorse companies or products that may advertise on other sites that may be referenced here.

  • Vitiligo JAK Inhibitor Update

    Ever since the report from Yale published about a vitiligo patient who improved after using Xeljanz (tofacitinib) and then our report about Jakafi (ruxolitinib) in another patient, there has been

    Read more
  • Vitiligo Simvastatin Clinical Trial Results

    Many of you have commented on this blog and sent emails asking about the results of a trial we conducted a number of years ago to test simvastatin (brand name Zocor) as a treatment for vitiligo

    Read more
  • Vitiligo research update in Rome!

    I just returned from the first Vitiligo International Symposium (VIS) held in Rome, Italy, where physicians and scientist from all over the world met to discuss their research. It was a great

    Read more